跳至主要内容
临床试验/EUCTR2006-001562-16-GB
EUCTR2006-001562-16-GB进行中(未招募)1 期

Studies of insulin action in patients at increased vascular risk. Modulation by antihypertensive and endocrine replacement therapy. - Studies of insulin action in patients at increased vascular risk

Royal Group of Hospitals Trust0 个研究点目标入组 45 人开始时间: 2006年9月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • -<65 years
  • -mild hypertension
  • -females with low levels of dehydroepiandrosterone for protocol (c)
  • -white western european origin
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -diabetes mellitus (except in protocol b where Hypertensive Type 2 diabetics are studied)
  • -significant obesity (weight exceeding 125% of the ideal)
  • -cardiac, renal or hepatic disease
  • -history of gout
  • -those receiving any treatment that may affect insulin action (except in protocol b)
  • -patients with secondary hypertension
  • -diastolic blood pressure outside 80-100mmHg range after placebo run-in of 6 weeks

研究者

发起方
Royal Group of Hospitals Trust

相似试验